Cytosorbents (CTSO) Capital Expenditures (2011 - 2026)
Cytosorbents' (CTSO) quarterly Capital Expenditures came in at $11000.0 in Q1 2026, up 450.0% YoY from $2000.0 in Q1 2025, and down 89.81% on a QoQ basis from $108000.0 in Q4 2025.
Cytosorbents (CTSO) Capital Expenditures (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Capital Expenditures data on file, last reported at $11000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 450.0% year-over-year to $11000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173000.0 (up 591.6% YoY) and the FY2025 annual result came in at $164000.0, up 1950.0% from the prior year.
- Capital Expenditures declined to $11000.0 in Q1 2026, from $108000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $5.6 million in Q3 2022 to a low of -$5.5 million in Q4 2022.
- A 5-year average of $77220.0 and a median of $27404.5 in 2024 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 563.68% in 2022, down 251.43% in 2022.
- Tracing CTSO's Capital Expenditures over 5 years: stood at -$5.5 million in 2022, then surged by 109.76% to $538115.0 in 2023, then sank by 138.47% to -$207000.0 in 2024, then jumped by 152.17% to $108000.0 in 2025, then slumped by 89.81% to $11000.0 in 2026.
- The last three Capital Expenditures figures came in at $11000.0 (Q1 2026), $108000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14,000.00 |
| Jun 30, 2026 | 14,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -207,000.00 |
| Dec 31, 2024 | -207,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 17,809.00 |
| Jun 30, 2024 | 17,809.00 |
| Mar 31, 2024 | 45,191.00 |
| Mar 31, 2024 | 45,191.00 |